Keryx Biopharmaceuticals (NASDAQ:KERX) Pares Friday's Losses After IPD Report - LLY, AZN, SNY

Pompano Beach, FL -- (SBWIRE) -- 02/04/2013 -- On Monday session at Wall Street, shares of Keryx Biopharmaceuticals (NASDAQ:KERX) were trading above the trend line after a huge decline observed on Friday session.

The 22% drop in Keryx Pharmaceuticals (KERX) observed on Friday was credited to issues initiated by a news from IPD Analytics regarding the firm’s ability to get FDA “New Chemical Entity” status for Zerenex, as per reported by The Street's Adam Feuerstein.

Where KERX is Headed Exactly? Find out in This Trend Analysis Reports

The author mentions that Amarin (AMRN) stock was sometimes unstable over the same issue, specifically that a major drug might not be able to safe NCE status, which gives five years of market exclusiveness for an exclusive pharmaceutical compound.

The IPD report given on Friday indicates that the active ingredient in Zerenex might not be distinguished sufficiently from Ferriseltz, created by the Japanese drugmaker Otusuka and FDA accepted in 1997 for use in MRI procedures.

At the current trading session, Keryx Biopharmaceuticals (NASDAQ:KERX) shares are down -1.41% to $7.02 while the stocks are trading within the range of $6.93 – $7.68. In the past year, the stock has traded within a range of $1.28 – $9.98. Average daily trading volume is 9.66 million shares.

Has KERX Found The Bottom and Ready To Move Up? Find Out Here

If we look at a few other stocks within industry, Eli Lilly & Co., AstraZeneca plc and Sanofi SA are in the losers list. Let’s have a quick look on their Market performance.

Eli Lilly & Co. (NYSE:LLY) shares are down -1.03% to $53.64 while the stock is trading within the range of $53.47 – $53.88 in the current trading session. In the last 12 months the shares have traded between $38.30 and $54.87. The average daily trading volume is 6.62 million shares.

Will LLY Get Buyers Even After The Recent Rally? Find Out Here

AstraZeneca plc (ADR) (NYSE:AZN) shares in the current session moved down -0.91% reaching $47.98. The stocks are trading in a range of $47.85 – $48.11. In the last year the stock has moved within a range of $39.72 – $50.14. The Company’s average daily trading volume is 1.43 million shares.

Is it the Right to Grab AZN after the Recent Slump? Get Free Trend Analysis Here

Another rival company, Sanofi SA (ADR) (NYSE:SNY), is trading down -4.08% to $47.28. Intraday trading recorded the stock price in a range of $47.17 to $48.34. In the previous 52 weeks the stock’s price ranged between $33.03 and $49.56. Their average daily trading volume is 1.28 million shares.

Has SNY Found The Bottom And Ready To Gain Momentum? Find Out Here

About TopStockPlays
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.

Disclaimer
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.